Future Biomarkers for Infection and Inflammation in Febrile Children

Judith Zandstra1,2, Ilse Jongerius1,2, Taco W Kuijpers2,3

  • 1Division Research and Landsteiner Laboratory, Department of Immunopathology, Sanquin Blood Supply, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.

Insights

New biomarkers help diagnose fevers from infections or inflammation. Combination tests using protein markers or transcriptomic analysis show promise for faster, tailored patient treatment.

Area of Science:

  • Biomedical diagnostics
  • Molecular biology
  • Clinical pathology

Background:

  • Febrile illnesses often present with overlapping symptoms, complicating accurate diagnosis.
  • Distinguishing between infection, inflammation, and autoimmune conditions is clinically challenging.
  • Effective patient management requires timely and precise etiological diagnosis.

Purpose of the Study:

  • To review novel biomarkers and discovery approaches for febrile conditions.
  • To assess current methods for differentiating infectious from non-infectious causes of fever.
  • To evaluate the potential of combined biomarker strategies in clinical diagnostics.

Main Methods:

  • Review of current plasma and whole blood biomarkers.
  • Analysis of RNA profiling and mass spectrometry data for infection discrimination.
  • Evaluation of biomarker utility in distinguishing infectious from non-infectious inflammatory diseases.

Main Results:

  • Current plasma and whole blood biomarkers show potential in differentiating bacterial and viral infections.
  • Biomarker approaches are being developed to distinguish infectious from non-infectious inflammatory conditions.
  • Combination tests, including protein markers and transcriptomic analysis, demonstrate significant advancements.

Conclusions:

  • Combined biomarker signatures, particularly using transcriptomic analysis, offer a promising avenue for improved febrile illness diagnostics.
  • Further exploration of these combination tests is crucial for accelerating early and tailored treatment decisions.
  • Advanced biomarker strategies can significantly enhance patient outcomes by enabling precise diagnosis and timely intervention.